Literature DB >> 1433256

Detection of bacterial interaction with lactoferrin by an enzyme-linked ligand binding assay (ELBA).

A R Kishore1, J Erdei, S Kalfas, A Forsgren, A S Naidu.   

Abstract

An enzyme-linked ligand binding assay (ELBA) was devised to measure the interaction between bacteria and human (H) or bovine (B) lactoferrin (Lf) linked to horseradish peroxidase. Reagents were calibrated for optimum colour development with o-phenylenediamine as chromophore and organisms that were either positive or negative in a radioisotope-labelled ligand binding assay (RLBA) with 125I-Lf. Good correlation of Lf binding (r = 0.89) was found between ELBA and RLBA with 169 randomly selected strains of Escherichia coli. A semi-quantitative scoring system for ELBA, corresponding to a similar system for RLBA, was established and shown to be valid for 517 strains from seven species of bacterial pathogens. ELBA was used to measure bacterial Lf binding-saturation and displacement kinetics and shown to be comparable with RLBA. ELBA may be a suitable method for examining the binding of Lf to bacteria without the need for radioactive isotopes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433256     DOI: 10.1099/00222615-37-5-341

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  Binding of hemoglobin to the envelope of Porphyromonas gingivalis and isolation of the hemoglobin-binding protein.

Authors:  S Fujimura; Y Shibata; K Hirai; T Nakamura
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium.

Authors:  S S Naidu; U Svensson; A R Kishore; A S Naidu
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

3.  Hemoglobin binding activity and hemoglobin-binding protein of Prevotella nigrescens.

Authors:  M Miyashita; S Oishi; A Kiso; Y Kikuchi; O Ueda; K Hirai; Y Shibata; Setsuo Fujimura
Journal:  Eur J Med Res       Date:  2010       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.